In this Friday’s PCT Grand Rounds, Greg Simon and Susan Shortreed of the Kaiser Permanente Washington Health Research Institute (KPWHRI) will present “Does Starting Buprenorphine Prevent Suicidal Behavior? What Trial Should We Emulate?”
The Grand Rounds session will be held on Friday, August 9, 2024, at 1:00 pm eastern.
Simon is a senior investigator at KPWHRI and a research professor of psychiatry and behavioral sciences at the University of Washington. He is a member of the leadership team for the NIH Pragmatic Trials Collaboratory Coordinating Center and was the principal investigator for the Suicide Prevention Outreach Trial (SPOT), an NIH Collaboratory Trial. Shortreed is a senior biostatistics investigator at KPWHRI and an affiliate professor of biostatistics at the University of Washington.